This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ana Kwokal: Innovator in HIV Treatment
Introduction
Ana Kwokal is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of HIV infection. Her innovative work has led to the development of new therapeutic options that can improve patient outcomes.
Latest Patents
Ana Kwokal holds 1 patent for her invention titled "Raltegravir salts and crystalline forms thereof." This patent encompasses new salts of Raltegravir and crystalline forms, as well as pharmaceutical compositions containing these salts. The invention also details methods for using these compositions to treat HIV infection and a process for preparing Raltegravir potassium.
Career Highlights
Ana is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work at Teva has allowed her to focus on innovative solutions for complex health issues, particularly in the realm of infectious diseases.
Collaborations
Ana has collaborated with notable colleagues, including Lilach Hedvati and Revital Burstein. These partnerships have fostered a collaborative environment that enhances the development of effective treatments.
Conclusion
Ana Kwokal's contributions to HIV treatment through her innovative patents exemplify her commitment to advancing medical science. Her work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile